(Q41009444)

25 September 2017

Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts (English)

1 reference

25 September 2017

1 reference

Park L

1

1 reference

25 September 2017

Raman KG

2

1 reference

25 September 2017

Lee KJ

3

1 reference

25 September 2017

Lu Y

4

1 reference

25 September 2017

Ferran LJ Jr

5

1 reference

25 September 2017

Chow WS

6

1 reference

25 September 2017

Stern D

7

1 reference

25 September 2017

Schmidt AM

8

1 reference

25 September 2017

language of work or name

English

0 references

publication date

1 September 1998

1 reference

25 September 2017

1 reference

25 September 2017

4

1 reference

25 September 2017

1025-1031

1 reference

25 September 2017

9

1 reference

https://scigraph.springernature.com/pub.10.1038/2012

25 September 2017

0 references

cites work

5-year incidence of atherosclerotic vascular disease in relation to general risk factors, insulin level, and abnormalities in lipoprotein composition in non-insulin-dependent diabetic and nondiabetic subjects.

1 reference

7 January 2021

Diabetes and cardiovascular disease. The Framingham study

1 reference

7 January 2021

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

7 January 2021

Glucose and diabetic vascular disease.

1 reference

7 January 2021

Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications

1 reference

7 January 2021

Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: a link between surface-associated AGEs and diabetic complications

1 reference

7 January 2021

Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of dia

1 reference

7 January 2021

The receptor for advanced glycation end products (RAGE) is a central mediator of the interaction of AGE-beta2microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway. Implications for the pathogenesis of dialysis-related amyl

1 reference

7 January 2021

Receptor for advanced glycation end products (AGEs) has a central role in vessel wall interactions and gene activation in response to circulating AGE proteins

1 reference

7 January 2021

Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats

1 reference

7 January 2021

Increased atherosclerosis in streptozotocin-induced diabetic mice

1 reference

7 January 2021

Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E

1 reference

7 January 2021

Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells

1 reference

7 January 2021

Streptozotocin-Induced Pancreatic Insulitis: New Model of Diabetes Mellitus

1 reference

7 January 2021

Metabolic control in 131 juvenile-onset diabetic patients as measured by HbA1c: relation to age, duration, C-peptide, insulin dose, and one or two insulin injections.

1 reference

7 January 2021

ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree

1 reference

7 January 2021

Quantitative assessment of atherosclerotic lesions in mice

1 reference

7 January 2021

The dark side of glucose

1 reference

7 January 2021

Immunological evidence for the presence of advanced glycosylation end products in atherosclerotic lesions of euglycemic rabbits

1 reference

7 January 2021

Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress.

1 reference

7 January 2021

The role of oxidized lipoproteins in atherogenesis

1 reference

7 January 2021

Is hyperglycemia associated with cardiovascular disease? The Framingham Study

1 reference

7 January 2021

A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection

1 reference

7 January 2021

Molecular identity and cellular distribution of advanced glycation endproduct receptors: relationship of p60 to OST-48 and p90 to 80K-H membrane proteins.

1 reference

7 January 2021

THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUM

1 reference

7 January 2021

The role of lipid peroxidation and antioxidants in oxidative modification of LDL.

1 reference

7 January 2021

Effect of the antioxidant N,N'-diphenyl 1,4-phenylenediamine (DPPD) on atherosclerosis in apoE-deficient mice

1 reference

7 January 2021

Identifiers

DOI

10.1038/2012

1 reference

25 September 2017

1 reference